Empirical Finance LLC decreased its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 45.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,469 shares of the company’s stock after selling 6,277 shares during the quarter. Empirical Finance LLC’s holdings in USANA Health Sciences were worth $765,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in USNA. BNP Paribas Arbitrage SA increased its stake in USANA Health Sciences by 199.2% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 15,532 shares of the company’s stock worth $1,591,000 after purchasing an additional 10,341 shares in the last quarter. Intersect Capital LLC bought a new stake in shares of USANA Health Sciences during the 2nd quarter worth approximately $200,000. State Board of Administration of Florida Retirement System grew its position in shares of USANA Health Sciences by 6.4% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 4,589 shares of the company’s stock valued at $470,000 after acquiring an additional 275 shares during the period. WINTON GROUP Ltd grew its holdings in USANA Health Sciences by 9.0% during the second quarter. WINTON GROUP Ltd now owns 25,358 shares of the company’s stock worth $2,597,000 after purchasing an additional 2,088 shares during the period. Finally, O Shaughnessy Asset Management LLC raised its holdings in USANA Health Sciences by 120.1% in the 2nd quarter. O Shaughnessy Asset Management LLC now owns 7,628 shares of the company’s stock valued at $781,000 after acquiring an additional 4,163 shares during the period. 54.77% of the stock is owned by institutional investors.
USANA Health Sciences stock opened at $89.40 on Wednesday. USANA Health Sciences, Inc. has a one year low of $72.03 and a one year high of $107.85. The stock’s 50 day moving average is $97.55 and its 200 day moving average is $99.17. The firm has a market cap of $1.79 billion, a P/E ratio of 13.48 and a beta of 0.85.
In other news, insider Brent Neidig sold 259 shares of the business’s stock in a transaction that occurred on Friday, June 18th. The stock was sold at an average price of $102.17, for a total transaction of $26,462.03. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Robert Auciaux sold 596 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, June 17th. The shares were sold at an average price of $101.72, for a total value of $60,625.12. Following the sale, the director now owns 298 shares in the company, valued at $30,312.56. The disclosure for this sale can be found here. Over the last quarter, insiders sold 4,290 shares of company stock valued at $418,924. 0.21% of the stock is owned by company insiders.
Separately, Zacks Investment Research cut USANA Health Sciences from a “buy” rating to a “hold” rating in a research report on Wednesday, August 25th.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.
Featured Story: What is a put option?
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.